Akros U.S. Tech 100 Index

Honeywell Aerospace spin-off is scheduled to be completed on June 29, 2026, marking the final step in the company's portfolio transformation. The new company will trade under the ticker 'HONA'. This event is scheduled.

First quarter fiscal year 2027 earnings release on 2026-06-09 scheduled, with analyst EPS and revenue estimates forecasted. Importance is Medium as earnings releases are significant catalysts with ≥5% expected impact.

Datadog's annual conference, DASH, is scheduled to take place in New York City on June 9-10, 2026. Low impact is estimated as conference announcements typically have minimal market effect, scheduled.

Cloudflare announced it will host an Investor Day on June 9, 2026. Low importance is estimated as investor days provide updates but rarely cause immediate large price swings, scheduled.

A quarterly dividend of $1.19 per share is scheduled to be paid on June 5, 2026, to shareholders of record as of May 17, 2026. This event is scheduled.

Medtronic is scheduled to report its financial results for the fourth quarter and full fiscal year 2026 on June 3, 2026. This event is expected to have a medium impact as earnings reports typically drive significant price volatility scheduled.

Q2 2026 earnings release is scheduled. The company guided for adjusted EPS between $0.51 and $0.55 and revenue between $9.6 billion and $10 billion. Expected price impact is estimated at 5% based on historical earnings volatility, scheduled.

Snowflake's Q1 fiscal year 2027 earnings report is scheduled. A medium impact is estimated based on typical earnings-related price movement.

Salesforce is scheduled to release its Q1 FY2027 earnings results on May 27, 2026, after market close. Importance is estimated as Low based on historical price stability during similar announcements, scheduled.

Synopsys is scheduled to report its Q2 fiscal year 2026 financial results after market close on May 27, 2026, scheduled; scheduled dates typically have minimal immediate impact.

FDA PDUFA target action date for LEQEMBI's subcutaneous autoinjector formulation (IQLIK SC-AI) for initiation dosing, a potential new administration option for the Alzheimer's disease treatment, scheduled for 2026-05-24. High impact expected due to the significant market potential of the Alzheimer's treatment.

Cummins Inc. 2026 Analyst Day scheduled for 2026-05-21. Strategic updates and long-term forecasts expected to impact stock price; importance estimated as Medium based on historical volatility during such events scheduled.

NVIDIA is scheduled to announce its financial results for the first quarter of fiscal year 2027, which ended on April 26, 2026, after market close on May 20, 2026. High importance is estimated as earnings reports typically trigger significant price movement, scheduled.

Analog Devices' Q2 2026 earnings release scheduled. Market reaction will depend on results versus expectations, scheduled.

An Investor Day is scheduled for May 20, 2026, where senior management will provide presentations scheduled.

Keysight Technologies fiscal second quarter 2026 earnings release scheduled for May 19, 2026. The company guided for revenue of $1.690-$1.710 billion and non-GAAP EPS of $2.27-$2.33. A medium impact is estimated as quarterly earnings releases typically result in price movements exceeding 5% scheduled.

Fiscal Q3 2026 earnings release on May 19, 2026 scheduled. Medium importance estimated based on historical price movement after earnings announcements.

Fiscal Q2 2026 earnings results are scheduled to be released on 2026-05-14. High importance is estimated as earnings results typically drive significant price volatility, with analysts forecasting EPS of approximately $2.66 forecasted.

Cisco's Q3 2026 earnings release and conference call are scheduled for May 13, 2026, scheduled.

Q1 2026 earnings release is scheduled for 2026-05-07. This event is estimated to have a high price impact as quarterly results often drive significant market volatility scheduled.

Microchip's Q4 and full fiscal year 2026 financial results conference call is scheduled for May 7, 2026. Analysts forecast revenue of approximately $1.26 billion and an adjusted EPS of $0.50. The market has priced in a potential post-earnings price move of over 11%, justifying the high importance scheduled.

Q1 2026 financial results and conference call scheduled for 2026-05-07. Analysts forecast revenue of ~$189 million and an EPS loss of ~$0.08, forecasted, scheduled. High importance estimated due to historical earnings-related price volatility exceeding 10%.

Cloudflare is scheduled to report its Q1 2026 financial results after the U.S. market closes on May 7, 2026. Medium importance is estimated as earnings releases typically cause significant price volatility, scheduled.

Q1 2026 earnings release is scheduled. Earnings announcements typically result in >5% price impact, scheduled.

Datadog is scheduled to report its first quarter fiscal year 2026 financial results on May 7, 2026. Low impact is estimated as the announcement of the reporting date itself typically has minimal market effect, scheduled.

AppLovin is scheduled to announce its Q1 2026 financial results after the market closes on May 6, 2026. This is a highly anticipated report, with market focus on the growth of its e-commerce advertising business. High importance is estimated due to the potential for significant price movement based on results and guidance, scheduled.

Axon is scheduled to report its first quarter 2026 financial results after the market closes on May 6, 2026, as announced by the company. This is a future event, so market impact is an estimate; earnings reports frequently cause significant price movement. scheduled

Coherent announced it will release its financial results for the third quarter of fiscal year 2026 on May 6, 2026, after the market closes. High importance is estimated due to the potential for significant price movement following earnings announcements, scheduled

Corning will host an investor event where it plans to provide an upgraded and extended 'Springboard' strategic plan through 2030 and introduce a new Photonics Market-Access Platform, which is scheduled. High importance estimated due to the potential for significant long-term valuation impact from the strategic update.

Fortinet is scheduled to announce its Q1 2026 financial results on May 6, 2026; analysts forecast EPS of $0.62 and revenue of $1.73 billion. This is rated medium as earnings are key volatility drivers forecasted and scheduled.

AMD fiscal Q1 2026 earnings results are scheduled to be released after market close on May 5, 2026; high impact expected as earnings typically drive >10% price volatility, scheduled.

Q1 2026 earnings release scheduled for 2026-05-05. Analysts forecast EPS of approximately $5.68-$5.79. High importance estimated due to previous 10.7% price impact scheduled.

Lumentum is scheduled to release its fiscal third quarter 2026 financial results after the market closes on May 5, 2026. Analysts forecast EPS of approximately $2.25 on revenue of $802.94 million, while the company's prior guidance was for EPS of $2.15–$2.35. High importance is estimated due to the potential for significant price volatility following the release. This release is expected.

Shopify is scheduled to announce its financial results for the first quarter of 2026 before markets open. High importance is estimated due to the potential for significant price movement typical of earnings releases, scheduled.

Arista Networks Q1 2026 financial results release after U.S. markets close on May 5, 2026; medium importance estimated due to high AI-driven demand expectations and typical earnings-related price volatility, scheduled

Rockwell Automation is scheduled to report its second quarter fiscal 2026 results on May 5, 2026, before the market opens, with a conference call to follow; Medium importance is estimated as earnings reports typically drive significant price volatility, scheduled

Palantir is scheduled to release its Q1 2026 financial results after the market closes on May 4, 2026. Market impact is estimated at >=5% as earnings releases are primary volatility drivers, scheduled.

Vertex Pharmaceuticals is scheduled to announce its first-quarter 2026 financial results after the market closes on May 4, 2026. This earnings release is estimated to have a >=5% price impact, scheduled

Apple's fiscal Q2 2026 earnings results and investor conference call are scheduled for April 30, 2026. Analysts forecast revenue around $109-112 billion forecasted. High importance is estimated due to potential >10% price impact scheduled.

Amgen is scheduled to report its first quarter 2026 financial results after the market close on April 30, 2026, followed by a conference call with management, scheduled. High importance is estimated due to typical volatility surrounding earnings releases.

Caterpillar to announce its first-quarter 2026 financial results on April 30, 2026, scheduled. High importance is estimated as earnings reports often result in price movements exceeding 10%.

First quarter 2026 financial results are scheduled to be reported after the market close on April 30, 2026. Analysts forecast strong results driven by demand in the AI sector. High importance is estimated as earnings releases for this sector often result in ≥10% price impact. This is scheduled

First quarter 2026 earnings release and conference call scheduled for April 30, 2026. Analysts forecast a loss per share, reflecting charges from recent acquisitions, forecasted. High importance estimated as earnings typically drive significant price movement, scheduled.

Roblox is scheduled to report its Q1 2026 financial results after the market closes on April 30, 2026. Analysts forecast a loss per share of approximately $0.41-$0.43, and the options market implies a potential price swing of over 14% post-announcement, which is forecasted and scheduled.

Sandisk is scheduled to report its third-quarter fiscal 2026 financial results on April 30, 2026. Analysts forecast significant growth, with EPS estimates around $13.5-$14.5 and revenue of $4.5-$4.7 billion. High importance is estimated due to the potential for significant price volatility following the earnings release, forecasted.

Alnylam is scheduled to report its Q1 2026 financial results before the market opens on April 30, 2026. Analysts forecast EPS of $1.50 and revenue of approximately $1.13 billion. A neutral impact is expected as the market usually anticipates these figures, scheduled.

The U.S. Department of Commerce halted shipments of certain semiconductor manufacturing tools to China's Hua Hong on 2026-04-29, introducing regulatory risk and potential negative impact on revenue. High importance is estimated due to the significant revenue contribution from the affected customer.

Amazon reported Q1 2026 net sales of $181.5B (up 17% YoY) and EPS of $2.78, beating analyst expectations. The results included a $16.8B pre-tax gain from its investment in Anthropic. AWS revenue grew 28% YoY. The company provided positive guidance for Q2 2026.

The U.S. FDA accepted for Priority Review the New Drug Application (NDA) for the investigational once-daily single-tablet HIV treatment regimen, bictegravir/lenacapavir (BIC/LEN) on 2026-04-29. This major regulatory milestone is estimated to have a high price impact of over 10% due to the significance of the HIV franchise.

Alphabet reported Q1 2026 revenue of $109.9 billion and EPS of $5.11, significantly beating analyst estimates of $107 billion and $2.67, respectively. High importance is estimated due to the massive EPS beat which is expected to drive a >10% price impact, expected.

Garmin reported record Q1 2026 results with revenue of approx. $1.75 billion (+14% YoY) and pro forma EPS of $2.08 (+29% YoY), beating analyst estimates. The company maintained its full-year 2026 guidance.

Reported Q3 2026 adjusted EPS of $3.37 and revenue of $5.94 billion, beating analyst expectations, and raised full-year fiscal 2026 guidance.

Reported Q1 2026 revenue of $2.48 billion (+2% YoY) and non-GAAP EPS of $3.57 (+18% YoY) on 2026-04-29, beating analyst expectations. The stock rose approximately 4.6% on the news.

Lowered full-year 2026 non-GAAP diluted EPS guidance to $14.25-$15.25 on 2026-04-29, from a prior range of $15.25-$16.25, to reflect charges related to business development activities.

Announced a strategic framework agreement with ProPetro's PROPWR business unit for the purchase of up to 2.1 gigawatts of power generation assets over five years, announced on April 29, 2026. Medium importance is estimated as this deal significantly impacts future capacity.

KLA released fiscal 2026 third-quarter results on 2026-04-29, reporting revenue of $3.415 billion and non-GAAP EPS of $9.40, with fourth-quarter revenue guidance above consensus, but the stock fell more than 7% in extended trading.

Reported Q1 2026 financial results on 2026-04-29, beating revenue and adjusted EPS estimates. However, the company raised its full-year capital expenditure guidance to $125-$145 billion, causing the stock to decline over 6% in after-hours trading.

Microsoft announced fiscal Q3 2026 results on April 29, 2026, with revenue of $82.9 billion and EPS of $4.27, beating analyst estimates. Azure revenue grew 40%. A 5% or greater price impact is estimated based on the significant earnings beat, expected.

Reports emerged of global job cuts, including 150 in Ireland, and concerns about key partner OpenAI missing internal growth targets, putting pressure on Oracle's stock due to its significant AI infrastructure investments.

Shopify and live-shopping platform Whatnot launched a direct integration, allowing merchants to automatically sync products, inventory, and orders between the two platforms. Medium importance is estimated as this integration expands Shopify's ecosystem.

Launched Agentforce Operations, an AI platform to automate back-office processes like inventory management and compliance checks, building on the acquisition of Regrello.

Medtronic received U.S. Food and Drug Administration (FDA) approval for the Mosaic Neo mitral valve, its next-generation mitral bioprosthesis, on April 29, 2026.

Reported Q2 2026 revenue of $10.6B (down 3% YoY) and non-GAAP EPS of $2.65, beating estimates. Issued Q3 revenue guidance of $9.2B-$10.0B and EPS of $2.10-$2.30, below consensus due to memory supply constraints. Stock fell ~4.5% in after-hours trading.

Announced an $833 million contract modification from the U.S. Navy for the production of Evolved SEASPARROW Missile (ESSM) Block 2 guided missile assemblies for the U.S. and allied nations.

On April 28, 2026, the U.S. FDA's CDER proposed to withdraw the approval for Amgen's drug Tavneos due to effectiveness and safety concerns. High importance is estimated as drug withdrawals significantly impact revenue and reputation.

Reported record Q1 2026 revenue of $751.1 million, a 130% year-over-year increase, and non-GAAP EPS of $0.44, significantly beating analyst estimates. Raised full-year 2026 revenue guidance from a midpoint of ~60% to ~80% year-over-year growth.

Corning reported Q1 2026 core sales of $4.35 billion (+18% YoY) and core EPS of $0.70 (+30% YoY), beating estimates. The company also announced two new long-term agreements with hyperscale customers. However, shares fell approximately 10% following the release, reportedly due to Q2 sales guidance falling slightly below analyst consensus.

NXP reported Q1 2026 revenue of $3.18 billion (+12% YoY) and non-GAAP EPS of $3.05, beating analyst estimates. The company also issued strong Q2 2026 guidance, forecasting revenue of $3.35-$3.55 billion, exceeding market expectations. This significant earnings beat and positive guidance are estimated to result in a price impact of 10% or more; expected.

Reported Q1 2026 revenue of $1.282 billion and non-GAAP EPS of $2.56 on 2026-04-28, beating analyst estimates. Despite the strong results driven by AI-related demand, the company's stock fell over 10% in subsequent trading, reportedly due to concerns over future growth and valuation.

Received U.S. FDA clearance and CE Mark approval for its next-generation Ultreon 3.0 Software, an AI-powered coronary imaging platform.

AMD announced its 'Advancing AI 2026' event on April 28, 2026, scheduled for July 23, 2026; medium impact expected as major event announcements typically influence price by ~5%.

On April 28, 2026, the FDA announced Amgen's participation in a new proof-of-concept pilot for real-time clinical trials (RTCT) for Imdelltra. Low importance is estimated as this is a procedural pilot program.

News reports on April 28, 2026 highlighted that company insiders sold approximately $339 million worth of stock over the prior three months, with no corresponding insider buying reported. Low importance is estimated as insider selling of this scale typically results in at least a 1% price impact, which is estimated

A South Korean court ruled in favor of Netflix on April 28, 2026, cancelling approximately KRW 68.7 billion in corporate taxes that had been imposed by the national tax authority. This is estimated to have a low market impact as the tax amount is small relative to the company's overall valuation.

Announced the opening of its U.S. flagship Bioprocess Design Center on April 28, 2026, to accelerate the development and manufacturing of biologics.

Announced a definitive agreement on April 27, 2026, to sell its microbiology business to private equity firm Astorg for approximately $1.075 billion. The transaction is expected to close in the second half of 2026.

Reported Q1 2026 revenue of $1.474 billion and non-GAAP EPS of $1.96, both beating analyst expectations. Raised full-year 2026 revenue guidance to $6.125-$6.225 billion, representing approximately 17% year-over-year growth. Medium importance estimated due to significant guidance raise.

Deadline for lead plaintiff appointment in a securities class-action lawsuit filed against Snowflake, concerning disclosures made between June 2023 and February 2024.

Northland Capital Markets downgraded AMD stock to Market Perform on April 27, 2026; low impact expected as single analyst actions typically cause 1-3% price movement.

Chief Strategy Officer Giovanni Barbarossa transitioned to the role of Special Advisor to the CEO on April 27, 2026, ahead of his planned retirement in September 2026.

Mizuho analysts upgraded CRWD stock to 'Outperform' from 'Neutral' and raised the price target to $520 on 2026-04-27. Importance is Low as analyst upgrades typically result in ≥1% price impact.

Awarded a $46.5 million contract modification on 2026-04-27 from Naval Air Systems Command for nine additional T408-GE-400 engines to support the U.S. Marine Corps' CH-53K King Stallion helicopter full-rate production.

Microsoft and OpenAI announced amended partnership terms on April 27, 2026, granting OpenAI more flexibility and making Microsoft's IP license non-exclusive. A 1% or greater price impact is estimated due to the structural partnership adjustment, expected.

Announced plans on 2026-04-24 to reduce its workforce by approximately 10%, or 8,000 jobs, to enhance efficiency and reallocate resources towards investments in artificial intelligence. This is estimated to have a medium impact (≥5%) due to the significant scale of restructuring.

On 2026-04-24, shareholders approved the 2026 Incentive Stock Program and Kevin Conroy was appointed to the Board of Directors, increasing the board size from twelve to thirteen members.

Alphabet announced its annual meeting for June 5, 2026, and filed proxy materials on April 24, 2026, including a proposal to add 200 million Class C shares to its 2021 Stock Plan. Low importance is estimated as this is a routine filing with expected <5% price impact, expected.

Medtronic disclosed in an 8-K filing on April 24, 2026, that it had identified unauthorized access to some of its IT systems, though no material impact is expected.

Shopify was announced as a founding member of the Universal Commerce Protocol (UCP) Tech Council, alongside Google, and joined by Amazon and Meta, to create open standards for AI-driven commerce. Low importance is estimated as this is a long-term industry initiative.

Intel reported Q1 2026 revenue of $13.6 billion and non-GAAP EPS of $0.29, significantly beating analyst forecasts. The strong results were driven by high demand for CPUs related to AI workloads. High importance is estimated due to the significant earnings beat expected.

Stock price dropped approximately 9% on April 23, 2026, due to a sector-wide sell-off in enterprise software triggered by a competitor's (ServiceNow) earnings report, not by company-specific news.

Reported Q1 2026 adjusted EPS of $2.45, beating estimates, but revenue of $9.14 billion missed expectations. The company reaffirmed its full-year 2026 outlook but lowered GAAP EPS guidance, citing impacts from geopolitical conflict. The stock declined over 5% following the report.

On or around April 23, 2026, Netflix's board of directors approved a new $25 billion share buyback program, signaling management's confidence in the company's value. This is estimated to have a medium market impact due to the significant scale of the program.

Successfully completed the 'Kakushin Rising' mission on 2026-04-23, deploying eight satellites for JAXA. Medium importance estimated as successful mission completions typically impact share price by 5-10%.

Reported Q1 2026 revenue of $11.01 billion and adjusted EPS of $5.44 on April 23, 2026, beating analyst consensus and raising full-year 2026 revenue and adjusted EPS guidance.

Announced an agreement to sell its Warehouse and Workflow Solutions (WWS) business to American Industrial Partners as part of its portfolio simplification strategy. The transaction is expected to close in the second half of 2026.

Awarded a $369.9 million contract modification from the U.S. Navy to procure F135 propulsion systems for the F-35 aircraft program.